RIZZI, Anna
 Distribuzione geografica
Continente #
NA - Nord America 7.804
EU - Europa 1.841
AS - Asia 997
Continente sconosciuto - Info sul continente non disponibili 3
SA - Sud America 3
OC - Oceania 2
Totale 10.650
Nazione #
US - Stati Uniti d'America 7.782
CN - Cina 668
UA - Ucraina 492
DE - Germania 418
TR - Turchia 302
GB - Regno Unito 255
IT - Italia 198
BE - Belgio 190
FI - Finlandia 117
SE - Svezia 91
RU - Federazione Russa 31
CA - Canada 22
FR - Francia 19
AT - Austria 11
IN - India 10
IR - Iran 7
PL - Polonia 5
A2 - ???statistics.table.value.countryCode.A2??? 3
HK - Hong Kong 3
HR - Croazia 3
BR - Brasile 2
GR - Grecia 2
NL - Olanda 2
NO - Norvegia 2
AE - Emirati Arabi Uniti 1
AU - Australia 1
BD - Bangladesh 1
BG - Bulgaria 1
CL - Cile 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
ES - Italia 1
IQ - Iraq 1
JP - Giappone 1
KW - Kuwait 1
NP - Nepal 1
NZ - Nuova Zelanda 1
RO - Romania 1
SG - Singapore 1
Totale 10.650
Città #
Fairfield 1.156
Woodbridge 1.108
Houston 656
Jacksonville 574
Ann Arbor 564
Ashburn 546
Chandler 513
Seattle 435
Wilmington 409
Cambridge 379
Brussels 189
Izmir 185
Nanjing 153
Beijing 144
Princeton 113
San Diego 101
Milan 99
Boardman 91
New York 74
Shanghai 68
Nanchang 60
Ferrara 55
Dearborn 54
Shenyang 47
Hebei 35
Bremen 34
Munich 28
Auburn Hills 25
Jiaxing 24
Mountain View 24
San Mateo 24
Falls Church 22
Mcallen 22
Norwalk 21
Tianjin 21
Changsha 19
Jinan 17
Montréal 17
Addison 16
London 16
Philadelphia 16
Zhengzhou 16
Redwood City 15
Helsinki 13
Kunming 13
Tappahannock 13
Indiana 12
Ningbo 10
Los Angeles 9
Washington 9
Orange 8
Verona 8
Vienna 8
Düsseldorf 7
Lanzhou 7
Des Moines 6
Guangzhou 6
Bologna 5
Hounslow 5
Prescot 5
Redmond 5
Warsaw 5
Ardabil 4
Augusta 4
Fuzhou 4
Islington 4
Monmouth Junction 4
Changchun 3
Chiswick 3
Edinburgh 3
Ferrara di Monte Baldo 3
Hangzhou 3
Hanover 3
Hefei 3
Leawood 3
San Francisco 3
Taizhou 3
Toronto 3
Zagreb 3
Bondeno 2
Bonn 2
Boston 2
Chicago 2
Hong Kong 2
Juiz De Fora 2
La Canada Flintridge 2
Leicester 2
New Bedfont 2
Pune 2
Wandsworth 2
Yellow Springs 2
Aberdeen 1
Acton 1
Amsterdam 1
Athens 1
Auckland 1
Bolzano 1
Bordeaux 1
Central 1
Chatsworth 1
Totale 8.428
Nome #
A novel and facile synthesis of tetra branched derivatives of nociceptin/orphanin FQ. 162
[(pF)Phe4,Arg14,Lys15]N/OFQ-NH2 (UFP-102), a highly potent and selective agonist of the nociceptin/orphanin FQ receptor 161
Characterization of FR 172357, a new non-peptide bradykinin B2 receptor antagonist, in human, pig and rabbit preparations 156
A new selective antagonist of the nociceptin receptor 146
Structure-activity studies on the nociceptin/orphanin FQ receptor antagonist 1-benzyl-N-{3-[spiroisobenzofuran-1(3H),4'-piperidin-1-yl]propyl} pyrrolidine-2-carboxamide. 142
Human vascular kinin receptors of the B-2 type characterized by radioligand binding 140
Kinin B-1 and B-2 receptors in pig vessels: characterization of two monoreceptor systems 138
[Nphe(1),Arg(14),Lys(15)]nociceptin-NH2, a novel potent and selective antagonist of the nociceptin/orphanin FQ receptor 137
Behavioural phenotypic characterization of CD-1 mice lacking the neuropeptide S receptor 134
Intrathecal administration of nociceptin/orphanin FQ receptor agonists in rats: A strategy to relieve chemotherapy-induced neuropathic hypersensitivity 134
Pharmacological characterization of nociceptin receptor: an in vitro study 133
[Dmt(1) ]N/OFQ(1-13)-NH(2) , a potent nociceptin/orphanin FQ and opioid receptor universal agonist. 130
A new ligand for the urotensin II receptor 129
Anxiolytic- and panicolytic-like effects of Neuropeptide S in the mouse elevated T-maze. 127
Synthesis and biological activity of human neuropeptide S analogues modified in position 2 124
In vitro and in vivo studies on UFP-112, a novel potent and long lasting agonist selective for the nociceptin/orphanin FQ receptor 123
Pharmacological studies on the NOP and opioid receptor agonist PWT2-[Dmt(1)]N/OFQ(1-13) 122
Pharmacology of [Tyr(1)]nociceptin analogs: receptor binding and bioassay studies 121
Pharmacological characterization of the nociceptin/orphanin FQ receptor non peptide antagonist Compound 24. 120
[Nphe(1)]nociceptin-(1-13)-NH2 antagonizes nociceptin effects in the mouse colon 119
[(t)Bu-d-Gly(5)]NPS, a pure and potent antagonist of the neuropeptide S receptor: In vitro and in vivo studies 119
Effects of vasoactive agents in healthy and diseased human saphenous veins 118
UFP-112 a Potent and Long-Lasting Agonist Selective for the Nociceptin/Orphanin FQ Receptor 117
Ala scan analogues of HOE 140. Synthesis and biological activities 115
Structure-activity study of the nociceptin(1-13)-NH2 N-terminal tetrapeptide and discovery of a nociceptin receptor antagonist 115
Synthesis and Biological Activity of Human Neuropeptide S Analogues Modified in Position 5: Identification of Potent and Pure Neuropeptide S Receptor Antagonists. 114
UFP-101 antagonizes the spinal antinociceptive effects of nociceptin/orphanin FQ; Behavioral and electrophysiological studies in mice 114
Endogenous nociceptin/orphanin FQ signalling produces opposite spinal antinociceptive and supraspinal pronociceptive effects in the mouse formalin test: Pharmacological and genetic evidences 113
Further studies on nociceptin-related peptides: Discovery of a new chemical template with antagonist activity on the nociceptin receptor 111
In vitro and in vivo pharmacological characterization of Pronetupitant, a prodrug of the neurokinin 1 receptor antagonist Netupitant 111
In vitro and in vivo pharmacological characterization of the novel neuropeptide S receptor ligands QA1 and PI1 110
Address and message sequences for the nociceptin receptor: A structure-activity study of nociceptin-(1-13)-peptide amide 110
null 110
Blockade of nociceptin/orphanin FQ receptor signaling in rat substantia nigra pars reticulata stimulates nigrostriatal dopaminergic transmission and motor behavior 109
Pharmacological characterisation of novel kinin B2 receptor ligands 108
Effects of human urotensin II in isolated vessels of various species; comparison with other vasoactive agents 108
[Arg(14), Lys(15)]nociceptin, a highly potent agonist of the nociceptin/orphanin FQ receptor: in vitro and in vivo studies 107
Studies on the antinociceptive effect of [Nphe(1)]nociceptin(1-13)NH2 in mice 106
Nociceptin/orphanin FQ receptor knockout rats: in vitro and in vivo studies. 106
Pharmacological characterization of tachykinin tetrabranched derivatives 106
Pharmacological characterization of the nociceptin receptor mediating hyperalgesia in the mouse tail withdrawal assay 105
Structure-activity study at positions 3 and 4 of human neuropeptide S. 105
In vitro and in vivo pharmacological characterization of the novel NK(1) receptor selective antagonist Netupitant. 105
null 105
Characterization of nociceptin receptors in the periphery: in vitro and in vivo studies 104
B1 and B2 kinin receptors in various species 104
In vitro functional characterization of novel nociceptin/orphanin FQ receptor agonists in recombinant and native preparations 104
Pharmacological profile of hemokinin 1: a novel member of the tachykinin family 102
Structure-activity relationships of nociceptin and related peptides: comparison with dynorphin A 101
Characterization of endothelin receptors in the human umbilical artery and vein 101
Further studies on the pharmacological features of the nociceptin/orphanin FQ receptor ligand ZP120 100
UFP-101, a peptide antagonist selective for the nociceptin/orphanin FQ receptor 100
Pharmacological characterisation of the first non-peptide bradykinin B2 receptor agonist FR 190997: An in vitro study on human, rabbit and pig vascular B2 receptors 100
Pharmacology of the Kallikrein-Kinin system 100
Further studies at neuropeptide s position 5: discovery of novel neuropeptide S receptor antagonists. 100
The nociceptin/orphanin FQ receptor antagonist, [Nphe(1)]NC(1-13)NH2, potentiates morphine analgesia 99
Nociceptin receptor activation inhibits tachykinergic non adrenergic non cholinergic contraction of guinea pig isolated bronchus 99
Bradykinin receptors and receptor ligands (with special emphasis on vascular receptors) 98
Urotensin II stimulates plasma extravasation in mice via UT receptor activation 98
Pharmacological characterization of the nociceptin/orphanin FQ receptor antagonist SB-612111 [(-)-cis-1-methyl-7-[[4-(2,6-dichlorophenyl)piperidin-1-yl] methyl]-6,7,8,9-tetrahydro-5H-benzocyclohepten-5-ol]: In vitro studies 97
The mouse vas deferens: A pharmacological preparation sensitive to nociceptin 97
Receptors for kinins in the human isolated umbilical vein. 96
Characterization of [Nphe(1)]nociceptin(1-13)NH2, a new selective nociceptin receptor antagonist 96
Nociceptin receptor binding in mouse forebrain membranes: Thermodynamic characteristics and structure activity relationships 95
Altered anxiety-related behavior in nociceptin/orphanin FQ receptor gene knockout mice 95
In vitro and in vivo pharmacological characterization of the nociceptin/orphanin FQ receptor ligand Ac-RYYRIK-ol 95
Neurobiology, pharmacology, and medicinal chemistry of neuropeptide S and its receptor 94
Structure-activity relationship study on human urotensin II 94
Contractile activity of endothelins and their precursors in human umbilical artery and vein: identification of distinct endothelin-converting enzyme activities 90
Pharmacological characterization of a vasopressin V1 receptor in the isolated human gastric artery 90
Nociceptin/orphanin FQ receptor ligands, 90
Spinal antinociceptive effects of the novel NOP receptor agonist PWT2-nociceptin/orphanin FQ in mice and monkeys 90
Endogenous nociceptin signaling and stress-induced analgesia 89
Pharmacology of [tyr1]nociceptin analogs: receptor binding and bioassay studies 88
Structure-activity studies of the Phe(4) residue of nociceptin(1-13)-NH2: Identification of highly potent agonists of the nociceptin/orphanin FQ receptor 88
Anxiolytic-like effect of neuropeptide S in the rat defensive burying. 88
Further studies on nociceptin/orphanin FQ related peptides: discovery of a new chemical template with antagonist activity on the OP4 receptor. 87
null 87
FR 173657: a new, potent, nonpeptide kinin B2 receptor antagonist. An in vitro study 87
Pharmacology of nociceptin and its receptor: a novel therapeutic target 86
Antinociceptive action of NOP and opioid receptor agonists in the mouse orofacial formalin test 85
In vitro and in vivo pharmacological characterization of nociceptin/orphanin FQ tetrabranched derivatives 85
null 84
Effects of naloxone benzoylhydrazone on native and recombinant nociceptin/orphanin FQ receptors 84
Peptide welding technology – A simple strategy for generating innovative ligands for G protein coupled receptors 80
null 79
In vitro characterization of J-113397, a non-peptide nociceptin/orphanin FQ receptor antagonist 78
Characterization of the human vascular kinin B2 receptor by binding assays. 76
Pharmacological characterization of the nociceptin/orphanin FQ receptor antagonist SB-612111 [(-)-cis-1-methyl-7-[[4-(2,6-dichlorophenyl)piperidin-1-yl]methyl]-6,7,8 ,9-tetrahydro-5H-benzocyclohepten-5-ol]: In vivo studies 74
Effects of Ro 64-6198 it nociceptin/orphanin FQ-sensitive isolated tissues 74
Structure-activity studies on neuropeptide S - Identification of the amino acid residues crucial for receptor activation 71
Receptor binding profile of novel nociceptin/orphanin FQ receptor ligands in mouse brain membranes. 71
In vitro characterization of FR 190997, the first non peptide B2 receptor agonist receptor binding and bioassay in the human umbilical vein 71
Neuropeptide S is a stimulatory anxiolytic agent: A behavioural study in mice 70
Involvement of the N/OFQ-NOP system in rat morphine antinociceptive tolerance: Are astrocytes the crossroad? 67
In vitro and in vivo pharmacological characterization of the neuropeptide S receptor antagonist [D-Cys(tBu)5]NPS. 65
MEN 11270, a novel selective constrained peptide antagonist with high affinity at the human B-2 kinin receptor 64
Receptor binding profile of novel nociceptin/orphanin FQ receptor ligands in mouse brain membranes 64
Further studies on nociceptin related peptides: discovery of new molecules with antagonist activity on the nociceptin receptor 60
Pharmacological characterization of the nociceptin receptors in the mouse: receptor binding, bioassay and behavioral studies 56
Totale 10.232
Categoria #
all - tutte 35.973
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 35.973


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20191.396 0 0 0 0 0 0 0 0 118 282 396 600
2019/20202.663 379 96 89 390 198 313 245 275 231 241 133 73
2020/20211.470 136 152 60 205 75 160 46 178 31 171 188 68
2021/20221.209 45 117 98 81 65 48 64 80 50 104 112 345
2022/20231.366 119 58 58 162 211 169 109 137 164 15 115 49
2023/2024533 82 135 31 23 41 131 24 57 9 0 0 0
Totale 10.750